click below
click below
Normal Size Small Size show me how
Heiman.pharm.vascev
Cholesterol Screening and drugs
Question | Answer |
---|---|
LDL Cholesterol – Primary Target of Therapy | <100 Optiimal 100-129: Near optimal/above optimal 130-159: Borderline high 160-189: High >190: Very high |
Total Cholesterol | <200: Desirable 200-239: Borderline High >240: High |
HDL Cholesterol | <40: low >60: High |
Risk Factors That Modify LDL Goals | Cigarette smoking Diabetes Hypertension (BP ≥ 140/90 mmHg or on antihypertensive medication) |
Risk Factors That Modify LDL Goals | Family history of premature CHD (CHD in male first degree relative < 55 years; CHD in female first degree relative < 65 years) Age (men ≥ 45 years; women ≥ 55 years) |
CHD or CHD Risk Equivalents | LDL Goal:<100 LDL level to TLC:>100 LDL to initiate drug therapy:>100 |
2+ Risk Factors | LDL Goal:<130 LDL level to TLC:>130 LDL to initiate drug therapy:≥ 130 mg/dL if 10-yr risk > 10%, ≥160 if 10-yr risk <10% |
0-1 Risk Factor | LDL Goal:<160 LDL level to TLC: >160 LDL to initiate drug therapy:>190 |
HMG-CoA Reductase Inhibitors | HMG-CoA reductase catalyzes the conversion of HMG-CoA to mevalonate in the liver Mevalonate is a cholesterol precursor These drugs are reversible, competitive inhibitors of this enzyme This results in the inhibition of cholesterol synthesis |